1. Worse, it caused patients to develop disabling movements called dyskinesias . 2. It was hoped that this would be effective for tardive dyskinesia . 3. Tardive dyskinesia is characterized by repetitive, involuntary, purposeless movements. 4. Dosages above approximately 300 mg / day risk inducing tardive dyskinesia . 5. A case report of adrafinil-induced orofacial dyskinesia exists. 6. Hypnogenic paroxysmal dyskinesia is a form of epilepsy affecting the frontal lobe. 7. Repetitive transcranial magnetic stimulation temporarily improves levodopa-induced dyskinesias . 8. Mutations in this gene are associated with paroxysmal kinesigenic dyskinesia . 9. Both typical and atypical antipsychotics can cause tardive dyskinesia . 10. Other closely related neurological disorders have been recognized as variants of tardive dyskinesia .
Mobile